ZVRA
Zevra Therapeutics Inc.
NASDAQ: ZVRA · HEALTHCARE · BIOTECHNOLOGY
$10.17
+5.17% today
Updated 2026-04-30
Market cap
$585.24M
P/E ratio
7.33
P/S ratio
5.50x
EPS (TTM)
$1.35
Dividend yield
—
52W range
$7 – $13
Volume
1.1M
Zevra Therapeutics Inc. (ZVRA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $12.84M | $13.29M | $28.65M | $10.16M | $27.46M | $23.61M | $106.47M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | +3.5% | +115.6% | -64.5% | +170.3% | -14.0% | +350.9% |
| Cost of revenue | — | — | — | $84000.00 | $175000.00 | $336000.00 | $324000.00 | $2.94M | $1.30M | $2.06M | $222000.00 | $2.94M | $7.42M | $16.48M |
| Gross profit | — | — | — | $-84000.00 | $-175000.00 | $-336000.00 | $-324000.00 | $9.89M | $11.98M | $26.59M | $9.94M | $24.52M | $16.20M | $89.99M |
| Gross margin | — | — | — | — | — | — | — | 77.1% | 90.2% | 92.8% | 97.8% | 89.3% | 68.6% | 84.5% |
| R&D | $2.99M | $3.37M | $11.92M | $13.93M | $20.47M | $20.59M | $41.76M | $19.41M | $8.84M | $10.16M | $19.80M | $39.81M | $42.09M | $12.74M |
| SG&A | $2.34M | $1.35M | $4.53M | $8.88M | $14.00M | $12.77M | $12.51M | $10.82M | $7.92M | $8.70M | $15.34M | $24.73M | $54.87M | $77.62M |
| Operating income | $-5.34M | $-4.72M | $-16.44M | $-22.81M | $-37.48M | $-33.37M | $-55.90M | $-20.34M | $-5.61M | $7.73M | $-42.56M | $-49.60M | $-87.00M | $-4.23M |
| Operating margin | — | — | — | — | — | — | — | -158.4% | -42.2% | 27.0% | -418.9% | -180.6% | -368.5% | -4.0% |
| EBITDA | $368886.00 | $-4.65M | $-16.37M | $-22.73M | $-34.30M | $-33.03M | $-53.94M | $-17.73M | $-5.43M | $-7.89M | $-25.53M | $-43.54M | $-76.40M | $98.71M |
| EBITDA margin | — | — | — | — | — | — | — | -138.1% | -40.9% | -27.5% | -251.2% | -158.6% | -323.6% | 92.7% |
| EBIT | $306322.00 | $-4.72M | $-16.44M | $-22.81M | $-34.47M | $-33.37M | $-54.27M | $-18.03M | $-5.70M | $-8.14M | $-26.47M | $-44.55M | $-82.79M | $94.66M |
| Interest expense | — | $157000.00 | $2.72M | $2.67M | $7.13M | $7.34M | $7.09M | $6.51M | $7.09M | $376000.00 | $335000.00 | $1.50M | $7.35M | $7.98M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-70416.00 | $-5.23M | $-24.45M | $-54.66M | $-16.52M | $-43.39M | $-56.47M | $-24.52M | $-12.76M | $-8.55M | $-26.77M | $-46.05M | $-105.51M | $83.23M |
| Net income growth (YoY) | — | -7321.6% | -367.9% | -123.5% | +69.8% | -162.7% | -30.1% | +56.6% | +48.0% | +33.0% | -212.9% | -72.0% | -129.1% | +178.9% |
| Profit margin | — | — | — | — | — | — | — | -191.0% | -96.0% | -29.9% | -263.5% | -167.7% | -446.9% | 78.2% |